Product Description: Tobevibart is an IgG1-lambda, anti-HBV (hepatitis B virus) surface envelope protein human monoclonal antibody. Tobevibart shows antiviral activity[1].
Applications: COVID-19-anti-virus
Formula: N/A
References: [1]International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 36, No. 2, 2022.
CAS Number: 2645440-65-7
Molecular Weight: N/A
Research Area: Infection
Solubility: H2O
Target: HBV